GSK sells Ribena and Lucozade for £1.35bn
It was recently reported that GlaxoSmithKline (GSK) have sold the Lucozade and Ribena drinks brands to Japanese firm Suntory for £1.35bn.
GSK chose to get rid of the well-known UK brands after deciding to focus on its core pharmaceuticals business.
from Lucozade and Ribena sold to Suntory for £1.35bn (BBC Business News, 9 September 2013).
For background information on the soft drinks market.
Soft Drinks (Carbonated and Concentrated) Market Update 2012 (19th Edition October 2012, Edited by Leah Tutt)
Note. All KeyNote market research reports are for the UK market.
Passport (formerly GMID) from Euromonitor has a number of report (see screenshot below) including
GlaxoSmithLinke Plc in Soft Drinks (United Kingdom), Local Company Profile 14 Jun 2013
Purchase of Lucozade Takes Suntory Holdings a Step Closer to Becoming A Truly Global Company, CAMI Article 09 Sep 2013
I choose “Ribena” for my searches – as a child I was a big fan
For more information on the deal between GSK and Suntory – search: